Psilera
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3201 W Hillsborough Ave # 151868, Tampa,...Website
www.psilera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Psilera
Psilera is a leading psychedelic-based biotechnology company with leadership from the pharmaceutical and science-driven cannabis industries to innovate new therapies for mental health. By leveraging strengths in research and a patient-focused approach, Psilera is building a proprietary drug pipeline consisting of novel compounds, formulations and a next-generation computational database. Based in Tampa, FL and working under DEA approval, Psilera will repurpose psychoactive natural products as building blocks for breakthrough medicines for mood, cognitive, and addiction disorders. The company was founded in 2019.Explore more
Psilera Org Chart
Get the full picture
Sign in to uncover key details.
JY
Director, Drug Discovery & Development
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Psilera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Psilera had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Psilera
Check out if Psilera is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Psilera recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Psilera has new funding data
Product Launch: Get notified when Psilera launches new products
Check if Psilera has recently received funding, and reach out quickly before it becomes old news!
Psilera, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Psilera
Find 3 more new buyers
Compare Similar Companies to Psilera
Compare insights from companies similar to Psilera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
<$5M
2002
SB
Stephen BergmeierChief Operating Officer and Director of Medicinal Chemistry
Company Profile Activity
Activity Insights
Psilera is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Psilera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Psilera.
Psilera financials insights
Gather financial insights about Psilera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$2.5M
2026
Seed
$8.8M
Psilera Tech Stack
A closer look at the technologies used by Psilera
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Project
Product Development, Intellectual Property, Bioengineering, Medical Research, Pharmaceuticals, Contracts, Healthcare Technology
Executive Move
Board of Directors
Funding
Psilera News & Media
Psilera Closes Oversubscribed $8.8M Seed Funding Round to Accelerate Neuroplastogen PSIL-006 Into the Clinic
TAMPA, Fla., May 28, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, today announced the successful closing of an oversubscribed $8.8 million Series Seed extension funding round led by...Psilera, Inc. to Present at Upcoming Industry and Investor Conferences
Management to present corporate update and highlight its next-generation neuroplastogen pipeline TAMPA, Fla., May 22, 2026 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation psychedelics and neuroplastogens, today announced that...Psilera Commends Landmark Executive Order Prioritizing Psychedelic Therapies
TAMPA, Fla., April 20, 2026 /PRNewswire/ -- Psilera, a leading biopharmaceutical company pioneering next-generation psychedelics and neuroplastogens, today issued a statement of strong support for the Executive Order signed on April 18, 2026. The order, titled "Accelerating Medical...Distinguished Neuroscience Expert Magali Haas, MD/PhD, Joins Psilera as Chief Medical Officer
The appointment expands the current Board of Directors' role to oversee Psilera's clinical development strategy for its next-generation neuroplastogens. TAMPA, Fla., Jan. 8, 2026 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a leading biopharmaceutical company developing groundbreaking...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Psilera
Sign Up For FreeTo access detailed company insights
Psilera is a leading psychedelic-based biotechnology company with leadership from the pharmaceutical and science-driven cannabis industries to innovate new therapies for mental health. By leveraging strengths in research and a patient-focused approach, Psilera is building a proprietary drug pipeline consisting of novel compounds, formulations and a... Read More
